HIV/AIDS Clinical Trials in New York

Showing 341-360 of 791 trials

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant

NCT02533934

Retrospective/Prospective, open-label study using sofosbuvir based DAA therapy to treat HIV/HCV coinfected pre or post liver transplant participants

HIVHepatitis CCirrhosis

University of California, San Francisco68 participantsStarted Aug 2016

San Francisco, California, United States • Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States +5 more locations

TERMINATEDPhase 3< 1 mile

Pregabalin Trial In HIV Neuropathic Pain

NCT01145417

This study examines the safety of pregabalin over a 6 month period in patients with neuropathic pain associated with HIV infection as an extension of another trial that tests the efficacy of pregabalin.

HIV-1 InfectionNeuropathic Pain

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.217 participantsStarted Jul 2010

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Burbank, California, United States +26 more locations

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant

Pregabalin Trial In HIV Neuropathic Pain

HIV/AIDS Trials in Other Cities

Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection

Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy

Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed

Development and Feasibility Testing of a Mobile Phone-Based HIV Primary Care Engagement Intervention

Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.

Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Improve Functional Health Status in Minority Women With HIV

IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV

Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment

Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women

HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance

A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults

Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Other Conditions in New York